FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher Reilly

Research Profile

Living Beings

Anatomy

Disorders

Chemicals & Drugs

Physiology

Organ Size

Procedures

Flow Cytometry

Co-author Network

Publications

TOP 3
Suzanne Marie Hirst; Ajay Karakoti; Sudipta Seal; William T Self; Sanjay Singh; Ron Tyler; Christopher M Reilly
Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice.
Shailendra Giri; Rondell P Graham; Ajay Karakoti; Jacie L Maguire; Ramandeep Rattan; Christopher M Reilly; Sudipta Seal; Viji Shridhar
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer.
Abdul Gafoor Puthiyaveetil; Christopher M Reilly; Benjamin Okyere; David Caudell
Diverging in vitro antibody isotype switching preference in B-lymphocytes from C57BL/6 and FVB mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher Reilly (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Suzanne Marie Hirst; Ajay Karakoti; Sudipta Seal; William T Self; Sanjay Singh; Ron Tyler; Christopher M Reilly
Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice.
Environmental toxicology 2013;28(2):107-18.
2013: Shailendra Giri; Rondell P Graham; Ajay Karakoti; Jacie L Maguire; Ramandeep Rattan; Christopher M Reilly; Sudipta Seal; Viji Shridhar
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer.
PloS one 2013;8(1):e54578.
2013: Abdul Gafoor Puthiyaveetil; Christopher M Reilly; Benjamin Okyere; David Caudell
Diverging in vitro antibody isotype switching preference in B-lymphocytes from C57BL/6 and FVB mice.
In vivo (Athens, Greece) 2013;27(1):29-39.
2013: Abdul Gafoor Puthiyaveetil; Christopher M Reilly; Timothy S Pardee; David L Caudell
Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome.
Leukemia research 2013;37(1):112-6.
2012: Abdul Gafoor Puthiyaveetil; Christopher M Reilly; Bettina Heid; Harm HogenEsch; David L Caudell
A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production.
Experimental hematology 2012;40(8):622-33.
2012: Samuel K Shimp; Marissanichole Rylander; David L Caudell; Cristen B Chafin; Sarah E Hammond; Molly A Read; Nicole L Regna; Christopher M Reilly
Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
Cellular & molecular immunology 2012;9(3):255-66.
2012: Samuel K Shimp; Alicia N Thomas; Cristen B Chafin; Carl D Parson; Nicole L Regna; Christopher M Reilly; M Nichole Rylander
HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factor-κB pathways.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2012;61(5):521-33.
2011: Kailin Yan; Nicolas L Young; Qiang Cao; Benjamin A Garcia; Christopher M Reilly; Nilamadhab Mishra
Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity.
The Journal of biological chemistry 2011;286(33):28833-43.
2011: Christopher M Reilly; Nicole Regna; Nilamadhab Mishra
HDAC inhibition in lupus models.
Molecular medicine (Cambridge, Mass.) 2011;17(5-6):417-25.
2011: Lirija Alili; Maren Sack; Ajay S Karakoti; Sarah Teuber; Katharina Puschmann; Suzanne M Hirst; Christopher M Reilly; Klaus Zanger; Wilhelm Stahl; Soumen Das; Sudipta Seal; Peter Brenneisen
Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions.
Biomaterials 2011;32(11):2918-29.
2010: Cristen Chafin; Raquel Hontecillas; Liwu Li; Sarah Muse; Josep Bassaganya-Riera; David L Caudell; M Nichole Rylander; Samuel K Shimp; John Zhang; Christopher M Reilly
Deletion of PPAR-γ in immune cells enhances susceptibility to antiglomerular basement membrane disease.
Journal of inflammation research 2010;3():127-34.
2009: Suzanne M Hirst; Ajay S Karakoti; Ron D Tyler; Nammalwar Sriranganathan; Sudipta Seal; Christopher M Reilly
Anti-inflammatory properties of cerium oxide nanoparticles.
Small (Weinheim an der Bergstrasse, Germany) 2009;5(24):2848-56.
2009: Amjad Mustafa; Steven D Holladay; Sharon Witonsky; Kurt Zimmerman; Christopher M Reilly; D Phillip Sponenberg; Danielle A Weinstein; Ebru Karpuzoglu; Robert M Gogal
Gestational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin disrupts B-cell lymphopoiesis and exacerbates autoimmune disease in 24-week-old SNF1 mice.
Toxicological sciences : an official journal of the Society of Toxicology 2009;112(1):133-43.
2009: URMILA MAITRA; Sarah Davis; Christopher M Reilly; Liwu Li
Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(9):5763-9.
2008: A Mustafa; Steven D Holladay; M Goff; Sharon G Witonsky; R Kerr; Christopher M Reilly; D Phillip Sponenberg; Robert M Gogal
An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD.
Toxicology and applied pharmacology 2008;232(1):51-9.
2008: Christopher M Reilly; Megan Thomas; Robert M Gogal; Selen Olgun; Arben Santo; Renna Sodhi; Eileen T Samy; Stanford L Peng; Gary S Gilkeson; Nilamadhab Mishra
The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice.
Journal of autoimmunity 2008;31(2):123-30.
2007: Julie Swenson; Selen Olgun; Ali Radjavi; Taranjit Kaur; Christopher M Reilly
Clinical efficacy of buprenorphine to minimize distress in MRL/lpr mice.
European journal of pharmacology 2007;567(1-2):67-76.
2006: Christopher M Reilly; Selen Olgun; David Goodwin; Robert M Gogal; Arben Santo; Jason W Romesburg; S Ansar Ahmed; Gary S Gilkeson
Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice.
European journal of immunology 2006;36(5):1296-308.
2006: A B Klein; Sharon G Witonsky; S Ansar Ahmed; S D Holladay; Robert M Gogal; L Link; Christopher M Reilly
Impact of different cell isolation techniques on lymphocyte viability and function.
Journal of immunoassay & immunochemistry 2006;27(1):61-76.
2004: Christopher M Reilly; Nilamadhab Mishra; Julie M Miller; Dimple Joshi; Phillip Ruiz; Victoria M Richon; Paul A Marks; Gary S Gilkeson
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(6):4171-8.
2003: Masahiro Masuya; Christopher J Drake; Paul A Fleming; Christopher M Reilly; Haiqun Zeng; William Hill; Angeline Martin-Studdard; David C Hess; Makio Ogawa
Hematopoietic origin of glomerular mesangial cells.
Blood 2003;101(6):2215-8.
2003: Nilamadhab Mishra; Christopher M Reilly; Doris R Brown; Phillip Ruiz; Gary S Gilkeson
Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.
The Journal of clinical investigation 2003;111(4):539-52.
2002: Jim Oates; Christopher M Reilly; Michelle B Crosby; Gary S Gilkeson
Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.
Arthritis and rheumatism 2002;46(3):598-605.
2002: Christopher M Reilly; Libby W Farrelly; Dana Viti; Shakisha T Redmond; Florence Hutchison; Phillip Ruiz; Pam Manning; Jane Connor; Gary S Gilkeson
Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
Kidney international 2002;61(3):839-46.
2002: Christopher M Reilly; Gary S Gilkeson
Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice.
Immunologic research 2002;25(2):143-53.
2001: Hideharu Sekine; Christopher M Reilly; Ivan D Molano; Gérard Garnier; Antonella Circolo; Phillip Ruiz; V Michael Holers; S A Boackle; Gary S Gilkeson
Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(10):6444-51.
2001: Christopher M Reilly; Jim Oates; J Sudian; Michelle B Crosby; Perry V Halushka; Gary S Gilkeson
Prostaglandin J(2) inhibition of mesangial cell iNOS expression.
Clinical immunology (Orlando, Fla.) 2001;98(3):337-45.
2000: Christopher M Reilly; Jim Oates; James A Cook; J D Morrow; Perry V Halushka; Gary S Gilkeson
Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(3):1498-504.
1999: Jim Oates; E F Christensen; Christopher M Reilly; Sally Self; Gary S Gilkeson
Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity.
Proceedings of the Association of American Physicians 1999;111(6):611-21.